IMPACT OF MOLECULAR MARKERS ON THE OUTCOME OF ACUTE MYELOID LEUKEMIA WITH INTERMEDIATE-RISK CYTOGENETICS

被引：0

作者：

Hoyos, M. ^{[1
]}

Brunet, S. ^{[2
]}

Tormo, M. ^{[2
]}

Ribera, J. M. ^{[2
]}

Nomdedeu, J. ^{[2
]}

Esteve, J. ^{[2
]}

Llorente, A. ^{[2
]}

Gallardo, D. ^{[2
]}

Queipo de Llano, M. P. ^{[2
]}

Duarte, R. ^{[2
]}

Heras, I. ^{[2
]}

Besalduch, J. ^{[2
]}

Bargay, J. ^{[2
]}

Marti, J. M. ^{[2
]}

Pedro, C. ^{[2
]}

Gonzalez, J. ^{[2
]}

Font, L. ^{[2
]}

Pratcorona, M. ^{[2
]}

Oriol, A. ^{[2
]}

Sierra, J. ^{[2
]}

机构：

[1] Hosp Santa Creu & Sant Pau, Barcelona, Spain

[2] CET LAM Cooperat Grp, Barcelona, Spain

来源：

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0640

引用

页码：268 / 269

页数：2

共 50 条

[21] Assessment of CEBPA Mutations Might Contribute to a Better Prognostic Assignment in Patients with Intermediate-Risk Cytogenetics Acute Myeloid Leukemia (AML).
Pratcorona, Marta
Torrebadell, Montserrat
Villamor, Neus
Rozman, Maria
Camos, Mireia
Carrio, Ana
Costa, Dolors
Beyaa, Marina Diaz
Montserrat, Emili
Esteve, Jordi
BLOOD, 2009, 114 (22) : 1024 - 1025
[22] Economic impact of genomic diagnostics for intermediate-risk acute myeloid leukaemia
Cressman, Sonya
Karsan, Aly
Hogge, Donna E.
McPherson, Emily
Bolbocean, Corneliu
Regier, Dean A.
Peacock, Stuart J.
BRITISH JOURNAL OF HAEMATOLOGY, 2016, 174 (04) : 526 - 535
[23] Prognostic implications of TdT expression in acute myeloid leukemia with an intermediate-risk karyotype
Masuho Saburi
Masao Ogata
Takako Satou
Yasuhiro Soga
Kazuhito Itani
Kazuhiro Kohno
Yoshiyuki Kondo
Toshiyuki Nakayama
International Journal of Hematology, 2020, 112 : 17 - 23
[24] Prognostic implications of TdT expression in acute myeloid leukemia with an intermediate-risk karyotype
Saburi, Masuho
Ogata, Masao
Satou, Takako
Soga, Yasuhiro
Itani, Kazuhito
Kohno, Kazuhiro
Kondo, Yoshiyuki
Nakayama, Toshiyuki
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (01) : 17 - 23
[25] Cytogenetics' impact on the prognosis of acute myeloid leukemia
Gupta, Monika
Mahapatra, Manoranjan
Saxena, Renu
JOURNAL OF LABORATORY PHYSICIANS, 2019, 11 (02) : 133 - 137
[26] Impact of FLT3ITD mutant allele level on relapse risk in intermediate-risk acute myeloid leukemia
Linch, David C.
Hills, Robert K.
Burnett, Alan K.
Khwaja, Asim
Gale, Rosemary E.
BLOOD, 2014, 124 (02) : 273 - 276
[27] Clinical significance of GSTM1 and GSTT1 polymorphisms in younger patients with acute myeloid leukemia of intermediate-risk cytogenetics
Lee, Ho Sup
Lee, Je-Hwan
Hur, Eun-Hye
Lee, Michael Jinpyo
Lee, Jung-Hee
Kim, Dae-Young
Kim, Se Hyung
Seol, Miee
Kang, Sol-IP
Ryu, Seong-Gil
Kang, Young-Ah
Lee, Young-Shin
Kang, Mun Jung
Seo, Eul-Ju
Kim, Yang Soo
Chi, Hyun Sook
Park, Chan Jeoung
Jang, Seongsoo
Yun, Sung-Cheol
Lee, Kyoo-Hyung
LEUKEMIA RESEARCH, 2009, 33 (03) : 426 - 433
[28] ACUTE MYELOID LEUKEMIA WITH INTERMEDIATE-RISK CYTOGENETICS AND A FAVORABLE GENOTYPE: PROGNOSTIC FACTORS AND RESULTS IN PATIENTS TREATED ACCORDING THE SPANISH CETLAM PROTOCOLS
Sierra, J.
Garrido, A.
Diaz-Beya, M.
Vives, S.
Pomares, H.
Guardia, R.
Cervera, M.
Queipo de Llano, M.
Salamero, O.
Garcia, A.
Marti-Tutusaus, J.
Pedro, C.
Bargay, J.
Sampol, A.
Hoyos, M.
Pratcorona, M.
Escoda, L.
Gallardo, D.
Arnan, M.
Ribera, J.
Esteve, J.
Nomdedeu, J.
Brunet, S.
HAEMATOLOGICA, 2017, 102 : 49 - 49
[29] Impact of Race on Outcomes in Intermediate Risk Acute Myeloid Leukemia
Abraham, Ivy
Patel, Anand Ashwin
Zhang, Yanyu
Liu, Li C.
Frankfurt, Olga
Khan, Irum
BLOOD, 2018, 132
[30] Focal Adhesion Genes Refine the Intermediate-Risk Cytogenetic Classification of Acute Myeloid Leukemia
Pallares, Victor
Hoyos, Montserrat
Carmen Chillon, M.
Barragan, Eva
Prieto Conde, M. Isabel
Llop, Marta
Falgas, Aida
Virtudes Cespedes, Maria
Montesinos, Pau
Nomdedeu, Josep F.
Brunet, Salut
Angel Sanz, Miguel
Gonzalez-Diaz, Marcos
Sierra, Jorge
Mangues, Ramon
Casanova, Isolda
CANCERS, 2018, 10 (11)

← 1 2 3 4 5 →